Momentum Is Strong For Nurix Therapeutics Inc (NASDAQ: NRIX)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $14.58 and fluctuated between $15.28 as its day high and $14.13 as its day low. The current market capitalization of Nurix Therapeutics Inc is $712.82M. A total of 0.73 million shares were traded on the day, compared to an average of 803.53K shares.

In the most recent transaction, van Houte Hans sold 6,812 shares of NRIX for 10.02 per share on Feb 16 ’24. After the transaction, the Chief Financial Officer now owns 68,333 company shares. In a previous transaction on Jan 30 ’24, Hansen Gwenn sold 2,334 shares at 7.99 per share. NRIX shares that Chief Scientific Officer owns now total 36,402.

Among the insiders who sold shares, Ring Christine disposed of 1,760 shares on Jan 30 ’24 at a per-share price of $7.99. This resulted in the Chief Legal Officer holding 17,427 shares of NRIX after the transaction. In another insider transaction, van Houte Hans sold 1,671 shares at $7.99 per share on Jan 30 ’24. Company shares held by the Chief Financial Officer now total 75,145.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NRIX has a high of $16.11 and a low of $4.22.

As of this writing, NRIX has an earnings estimate of -$0.8 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.64 per share and a lower estimate of -$0.95. The company reported an EPS of -$0.68 in the last quarter, which was 10.50% higher than expectations of -$0.76.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NRIX’s latest balance sheet shows that the firm has $295.72M in Cash & Short Term Investments as of fiscal 2021. There were $13.04M in debt and $66.26M in liabilities at the time. Its Book Value Per Share was $4.12, while its Total Shareholder’s Equity was $342.30M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NRIX is Buy with a score of 4.64.

Most Popular

Related Posts